A Phase 1 interventional study of Dexamethasone and Distilled Water in Induction of Labor Affected Fetus / Newborn, sponsored by samar sayed el sayed. Completed at 1 site in Egypt. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-05.
Sponsored by samar sayed el sayed · Phase 1, Interventional, and Other
This study aims to evaluate the effect of intravenous injection of a single dose of dexamethasone in shortening the duration interval between initiation of labor induction and delivery of the fetus in primigravida full-term pregnancy.
Research hypothesis:
In full term primigravidae undergoing induction of labor, the use of a single dose of dexamethasone (8mg) intra-venously will help in shortening the duration interval between initiation of labor induction and delivery of the fetus.
Research question:
In full term primigravidae undergoing induction of labor, does the use of intra-venous dexamethasone play a role in shortening the duration interval between initiation of labor induction and delivery of the fetus?
Patients and Methods
Type of study:
Double blind randomized controlled trial.
Study settings:
Site: Ain Shams Maternity Hospital Study duration: 6 months
Study population:
One hundred and two pregnant women will be recruited in this study from women attending the emergency room department of obstetrics and gynecology at Ain Shams University.
Inclusion criteria:
Primiparity Singleton pregnancy Gestational age i.e. 40 weeks or more by date or 1st trimestric ultrasound. Bishop score of 4 or greater. Longitudinal lie. Vertex presentation. Intact membranes
Exclusion criteria:
Refused consent Malpresentation. Multiple pregnancies. Active phase of labour. Rupture of membranes (ROM). Cephalo-pelvic disproportion. Previous C-section or myomectomy operation. Known contraindication or hypersensitivity to Dexamethasone. Fetal distress. IUFD Current maternal disorder e.g. diabetes mellitus and pregnancy induced hypertension.
Over distended abdomen e.g. fetal macrosomia or polyhydramonus suggested by ultrasound.
Ante-partum hemorrhage e.g. placenta previa, accidental hemorrhage.
These criteria will be assessed at first during the initial evaluation in the delivery suite as follows:
History:
Personal, menstrual, obstetric, past and family history will be taken. History of present pregnancy will be taken including the first day of last menstrual period, duration of pregnancy, warning symptoms as headache, visual symptoms, edema of face and fingers, excessive vomiting, heart burn, epigastric pain, vaginal bleeding, decreased fetal movements, edema of the lower limbs and history of any drug intake.
Examination:
Investigations:
Enrollment and Allocation of the patients:
After approval of health ethical committee in Ain Shams Hospital and after the initial evaluation, women who fulfilled the appropriate inclusion and exclusion criteria will be invited to participate in the study, a verbal consent will be obtained from each candidate after explanation of the procedure in details.
Randomization:
The eligible 102 women will be randomized into one of the following two groups:
No cervical ripping agent will be used for induction of labor in either group. Randomization is performed using a computer-generated randomization system. 102 opaque envelopes will be numbered serially; each envelope will contain the corresponding letter in the randomization table, and when the first pregnant woman arrived, the first envelope will be opened and the pregnant woman will be allocated to the group according to the inside letter.
This is the only study on the registry with samar sayed el sayed as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
including 51 women who will receive a prefilled syringe with two milliliters (8 mg) of dexamethasone intravenously.
Drug: Dexamethasone
including 51 women who will receive a prefilled syringe with two milliliters of distilled water intravenously.
Drug: Distilled Water
a prefilled syringe with two milliliters (8 mg) of dexamethasone intravenously
Also known as: Drug group
a prefilled syringe with two milliliters of distilled water intravenously.
Also known as: Placebo group
The interval between the initiation of induction and the delivery of the fetus.
Mean time of interval between the initiation of induction and the delivery of the fetus in the two groups.
Time frame: Up to 1 day
The duration of the first stage of labor (Partographic representation will do for each participant).
Mean time of duration of the first stage of labor in the two groups.
Time frame: Up to 1 hour
The duration of the second stage of labor.
Mean time of duration of the second stage of labor in the two groups.
Time frame: Up to 2 hours
The duration of the third stage of labor.
Mean time of duration of the third stage of labor in the two groups.
Time frame: Up to 30 minutes
The neonatal outcome by APGAR score.
Mean of APGAR score at 1 and 5 minutes for fetus in the two groups.
Time frame: at 1 and 5 minutes
Any postpartum maternal adverse effects (e.g. vital sing abnormality, any maternal postpartum hemorrhage and central nervous system manifestation).
Percentage of postpartum adverse effects in both group.
Time frame: Up to 1 day
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.